We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Immune-Related Gene Implicated in Chronic Candida Infection Risk

By LabMedica International staff writers
Posted on 26 Jun 2019
Print article
Image: A scanning electron photomicrograph of Candida albicans yeast cells (Photo courtesy of Science Photo Library).
Image: A scanning electron photomicrograph of Candida albicans yeast cells (Photo courtesy of Science Photo Library).
Candida vaginitis is a frequent clinical diagnosis with up to 8% of women experiencing recurrent vulvovaginal candidiasis (RVVC) globally. RVVC is characterized by at least three episodes per year.

Although Candida often turns up as a harmless, commensal organism in healthy individuals, the fungus can prompt serious, systemic infections in immunocompromised individuals and contributes to even more common non-invasive mucosal infections. In particular a significant proportion of women go through several vulvovaginal Candida yeast infections annually, including many who lack non-genetic risk factors such as prolonged antibiotic or oral contraceptive use.

A large team of international scientists led by the Radboud University Medical Center (Nijmegen, Netherlands) carried out exome sequencing on women from two European cohorts: 80 cases and 77 controls from southern Europe and, from northern Europe, 75 affected women and 95 unaffected controls. The investigators used Agilent SureSelect enrichment kits, and Illumina instruments.

The team also used in vitro methods such as flow cytometry, enzyme-linked immunosorbent assays, or gene silencing to track cytokine responses to Candida in 73 of the control individuals, uncovering fungus-related shifts that were subsequently verified in 50 more participants. They fed those findings into a Candida-related cytokine quantitative trait locus (QTL) analysis, which was considered alongside exome sequences to identify SNPs, genes, and pathways contributing to frequent Candida infections.

The scientists identified genes and cellular processes that contribute to the pathogenesis of RVVC, including cellular morphogenesis and metabolism, and cellular adhesion. They further identified SIGLEC15, a lectin expressed by various immune cells that binds sialic acid–containing structures, as a candidate gene involved in RVVC susceptibility. Candida stimulation induced SIGLEC15 expression in human peripheral blood mononuclear cells (PBMCs) and a polymorphism in the SIGLEC15 gene that was associated with RVVC in the patient cohorts led to an altered cytokine profile after PBMC stimulation.

The same polymorphism led to an increase in IL1B and NLRP3 expression after Candida stimulation in HeLa cells in vitro. Last, SIGLEC15 expression was induced by Candida at the vaginal surface of mice, where in vivo silencing of SIGLEC15 led to an increase in the fungal burden. SIGLEC15 silencing was additionally accompanied by an increase in polymorphonuclear leukocytes during the course of infection. Identification of these pathways and cellular processes contributes to a better understanding of RVVC and may open new therapeutic avenues. The study was published on June 12, 2019, in the journal Science Translational Medicine.

Related Links:
Radboud University Medical Center

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.